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I 
n  this  issue  of the Journal  of Experimental Medicine, 
Stockinger and her colleagues describe their work on the 
role  of B  cells,  dendritic  cells,  and macrophages  in  the 
induction of IL-4 synthesis by T  cells (1). Two clear con- 
clusions emerged from this study. First, whereas there was a 
requirement for DC in the primary activation of T  cells, B 
cells played an essential  role in the induction of IL-4 gene 
expression by the T  cells that provided helper activity for 
antibody synthesis. Second, DC and macrophages together 
were the most potent inducers of IFN-~/. 
As the authors remark, experiments to establish  the role 
of B  cells in the programming of T  cells to produce IL-4 
have  given apparently  conflcfing results,  and  the  subject 
has  an interesting history. Early experiments in vitro  (for 
review see 2) showed that the induction of IL-4-producing 
T  cells  required the  presence of IL-4 in  the  culture me- 
dium. Were this to be the case in vivo, then there would 
be the problem of how IL-4 synthesis was  ever initiated. 
Whereas  it was  recognized that basophils  produced  IL-4 
(3),  they were not attractive candidates for the apparently 
essential  initial source of IL-4, because their anatomical lo~ 
cation was inappropriate to such a role. However, two pos- 
sible alternative solutions were apparent. 
First,  it was  shown  that  the  activation of Th-2  T  cell 
clones in vitro was dependent on the presence of B  cells, 
whereas  the prohferation of Th-1  clones was  favored by 
costimulation with  adherent cells  (4).  These observations 
led to the hypothesis that both Th-1 and Th-2 clones de- 
rived from a common precursor but that after primary acti- 
vation, the subsequent contact with different types of APC 
determined which way the  differentiation proceeded (4). 
Support for these in vitro experiments came from earlier 
experiments in vivo that had shown that the polyclonal ac- 
tivation of murine B  cells by the injection of rabbit anti- 
mouse IgD induced high levels of IL-4 synthesis and IgE 
production (5). 
Second, although these experiments seemed to establish 
a role for B  cells in the induction of IL-4 synthesis by T 
cells,  they did not exclude other mechanisms for such in- 
duction. B  cells might be sufficient, but were they neces- 
sary? The discovery of a small subset ofmurine thymocytes 
that  promptly  secreted  IL-4  on  activation  and  that  ex- 
pressed the  NK  cell antigen NKI.1  (6)  indicated that an 
atypical  subset  of T  cells  existed  that  were  already pro- 
grammed for the synthesis of this cytokine. These cells had 
other unusual  characteristics;  some  were  CD4 §  whereas 
others were CD4-CD8-, but all were apparently restricted 
to the non-MHC-hnked,  class I-hke antigen,  CD1.  The 
capacity of these cells to produce large amounts of IL-4 on 
primary activation has lead to the suggestion that they may 
promote Th-2-hke T cell responses (7), but currently there 
is  no  estabhshed  role  for these  cells  (6).  Further,  recent 
studies on mice in which class II MHC antigen expression 
has  been  ehminated  by homologous recombination have 
demonstrated  that these  animals  contain  CDl-restricted 
TCtk-ot/[3  +  CD4 +  T  cells,  only some  of which  express 
NKI.1  (8).  Consequently, it may be that in normal mice 
there are more CDl-restricted T  cells than have been rec- 
ognized hitherto, and this possibihty makes identification of 
the function of these cells a pressing matter. However, with 
regard to the question of the role of  B cells in the induction 
of T  cell cytokines, three features of these atypical T  cells 
were remarkable: first, some were found in the B cell areas 
of lymphoid tissue;  second,  of seven T  cell lines derived 
from these cells,  two were activated by B  cells;  third, the 
activation of these cells in vitro with B  cells induced the 
latter to prohferate but not to terminally differentiate into 
antibody-secreting cells (9). These results await a full inter- 
pretation, but since it has been shown that B cell activation 
by  cross-linking  of surface  Ig  primes  B  cells  for  IL-4- 
induced prolifekation (10) and that activated B cells upreg- 
ulate their expression of CD1  (11),  it is reasonable to sug- 
gest  that  the  physiological  role  of  the  CDl-restricted 
CD4 + T  cells in B  cell follicles is to induce the expansion 
of antigen-activated B  cells.  Such a mechanism retains the 
classical  T  cell  control  of antibody  synthesis,  since  the 
CDl-restricted T  cells can induce B  cell proliferation but 
not  antibody synthesis.  The  physiological significance  of 
such a process is clear: it implies that B  cells, hke T  cells, 
may undergo clonal expansion before the two cell types in- 
teract, the result being that the probability that such anti- 
gen-specific interactions will actually occur is greatly aug- 
mented. 
This hypothesis would predict that antibody synthesis in 
animals  that lack CDl-restricted T  cells would be greatly 
impaired.  In  the  experiments  of Stockinger and  her  co- 
workers, the mice used were transgenic for the T  cell re- 
ceptor that recognized a peptide fragment of murine C5 in 
the context of I-E  k, and consequently they would be defi- 
cient in  CDl-restricted T  cells.  Interestingly, these mice, 
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are not tolerant to it, were unable to make an antibody re- 
sponse to this antigen when immunized, whereas nontrans- 
genic congenic mice were able to do so. This result is con- 
sistent  with  a  role  for CDl-restricted  T  cells  in  antibody 
synthesis,  but  other  explanations  are  also  possible.  As 
Stockinger observes, in the TCI< transgenic mice the C5- 
specific T  cells  greatly outnumber any C5-specific B  cells, 
and  this  imbalance  may have  impaired  antibody  produc- 
tion, possibly by the hyperproduction of IFN-~/(12). 
However,  in  two  experimental  systems  it  has  proved 
possible to induce IL-4 synthesis in the  absence of B  cells. 
In the first of these, SCID mice were injected with highly 
purified  T  cells  from normal donors and immunized with 
KHL in alum. Control SCID mice received both B  and T 
cells before immunization (13). The induction of IL-4 syn- 
thesis  was  found to be  independent  of the  presence  of B 
cells  in  the  donor inoculum.  Furthermore,  it  was  shown 
that normal mice could be primed for IL-4 synthesis by in- 
jecting them with purified DCs pulsed in vitro with KLH. 
Whereas  these  results  appeared  to show  that B  cells  were 
not essential for priming T  cells for IL-4 synthesis, it could 
be argued that in all  these  experiments  the T  cells  had al- 
readly been primed  by cross-reactive  environmental  anti- 
gens. Given the high level of cross-reactivity among T  cells 
(14), this possibility cannot be completely dismissed.  How- 
ever, such a caveat could not apply to the second series of 
experiments.  In  these,  mice  rendered  genetically  B  cell- 
deficient by the introduction of a deletion mutation in the 
transmembrane  region of B  cell surface  IgM were immu- 
nized with KLH in CFA. As with the SCID mice, priming 
for IL-4 synthesis in these deletion mutants was comparable 
to  that  of controls  (15).  Although  these  B  cell-deficient 
mice have  not been examined  for their  content  of CD1- 
restricted  CD4 +  T  cells,  there  is  no  reason  at  present  to 
suppose  that  these  cells  are  also lacking,  and  they remain 
therefore a possible explanation for the apparent difference 
between  the  TCR  transgenic  experiments  of Stockinger 
and the experiments with B cell-deficient mice. 
If this explanation proves to be the  case,  are we able  to 
conclude that there  are at least  two ways that T  cells  may 
be  induced  to  differentiate  into  IL-4-secreting  cells  with 
one  depending  only  on  B  cells  and  the  other  on  CD1- 
restricted,  IL-4-producing T  cells? At present this question 
remains  to  be  resolved.  In  the  TCR  transgenic  mice  of 
Stockinger  and  her  colleagues,  the  T  cells  expressing  the 
TCP, transgene were induced into IL-4 gene expression in 
vitro by culturing them with specific  antigen  in the pres- 
ence of DCs and B  cells  that had been activated with LPS. 
Further, in the in vivo experiments, B cells primed in non- 
transgenic donors were used to induce IL-4 synthesis in the 
TCR  transgenic T  cells.  These experiments lead to an im- 
portant conclusion, specifically, that after primary B cell ac- 
tivation has taken place, these cells are competent to induce 
IL-4 synthesis in T  cells.  However, the experiments do not 
address the question of whether B  cell priming for T  cell- 
dependent responses is itself an autonomous function of na- 
ive resting B cells requiring only antigen. An alternate view 
might be that such priming requires the clonal expansion of 
B  cells driven by IL-4 produced by CDl-restricted T  cells. 
Further  developments  in  this  very active  field  are  antici- 
pated with interest. 
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Note added in proof." Direct evidence for the involvement of  CD4 +, NK. 1.1 + T cells in the induction of IL-4- 
dependent responses has been reported.  (Yoshimoto,  T., A. Bendelac, J. Hu-Li, and W.E. Paul. 1995. Ab- 
stract IX International  Congress of Immunology. San Francisco, CA.) The absence of CD4 +, NK.I.1 + T 
cells in [32-m  -/- mice accounts for their failure to produce IgE in response to anti-IgD. 
ReFerences 
1.  Stockinger, B.,  T.  Zal,  A.  Zal,  and D.  Gray.  B  cells solicit 
their own help from T cells.J.  Exp. Med. 183:891-899. 
2.  O'Garra, A., and K. Murphy. 1994. Role of cytokines in de- 
termining T-lymphocyte function.  Curr. Opin.  Immunol. 6: 
458--466. 
3.  Paul,  W.E.,  R.A.  Seder,  and M.  Plaut.  1992.  Lymphokine 
and cytokine production by FceR1 + cells. Adv. lmmunol. 53: 
1-29. 
4.  Gajewski,  T.F., S.R.  Schell,  G. Nau, and F.W. Fitch.  1989. 
Regulation  of T-cell  activation:  differences  among  T-cell 
subsets. Immunol. Rev.  111:79-110. 
5.  Finkelman,  F.D., J. Ohara, D.K. Goroff, J.  Smith, N. Villa- 
creses, J. Mond, and W.E. Paul.  1986.  Production of BSF-1 
during an in vivo, T-dependent immune response. J. Immunol. 
137:2878-2885. 
6.  Bendelac,  A. 1995. Mouse NK1 + T  cells. Curr. Opin.  Immu- 
nol. 7:367-374. 
7.  Yoshimoto, T., and W.E. Paul.  1994. CD4 + NKI.I + T cells 
promptly produce IL-4 in response  to in vivo challenge  with 
anti-CD3.J. Exp. Med. 179:1285-1295. 
8.  Cardell,  S., S. Tangri,  S. Chan, M. Kronenberg, C. Benoit, 
and D. Mathis.  1995. CDl-restricted CD4 + T  cells in major 
718  Commentary histocompatibility complex  class  II-deficient mice. J.  Exp. 
Med.  182:993-1004. 
9.  Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, 
C. Benoit, and D. Mathis. 1991.  Mice lacking MHC class II 
molecules. Cell. 66:1051-1066. 
10. Klaus, G.G.B., M.K.  Bijsterbosch, A.  O'Garra, M.M.  Har- 
nett,  and  K.P.  Rigley.  1987.  Receptor  signalling  and 
crosstalk in B lymphocytes. Immunol. Rev. 99:19-38. 
11. Della, D., G. Cattoretti, N. Polli, E. Fontanella, A. Aiello, R. 
Giardini, F. Rilke, and G. Della-Porta. 1988.  CDlc but nei- 
ther CDla nor CDlb molecules are expressed on normal, ac- 
tivated, and malignant human B cells: identification of a new 
B-cell subset.  Blood. 72:242-247. 
12. Mond, J.J., F.D. Finkelman, C. Sarma, J. Ohara, and S. Set- 
rate. 1985. Recombinant interferon-~/inhibits the B cell pro- 
liferative response stimulated by soluble but not sepharose- 
bound  anti-immunoglobulin  antibody. J.  Immunol.  135: 
2513-2517. 
13. Ronchese,  F., B.  Hausmann,  and G. Le Gros.  1994.  Inter- 
feron-~/ and interleukin-4-producing T  cells can be primed 
on dendritic cells in vivo and do not require the presence of  B 
cells. Eur. J. Immunol. 24:1148-1154. 
14. Nanda,  K., K.K.  Arzoo, H.M.  Geysen, A.  Sette,  and E.E. 
Sercarz.  1995.  Recognition of multiple peptide cores by a 
single T cell receptor.J. Exp. Med.  182:531-539. 
15. Epstein, M.M.,  F.  Di  Rosa,  D. Jankovic,  A.  Sher,  and  P. 
Matzinger. 1995. Successful T cell priming in B cell-deficient 
mice.J. Exp. Med.  182:912-922. 
719  Mason 